C4 THERAPEUTICS INC (CCCC)

US12529R1077 - Common Stock

6.43  -0.11 (-1.68%)

After market: 6.2667 -0.16 (-2.54%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
20.76M31.10M45.79M33.20M21.38M
Operating Expenses
159.79M160.63M127.92M93.64M56.83M
Research and Development
117.71M117.84M94.67M78.44M46.56M
Selling, General, and Administrative Expenses
42.08M42.79M33.25M15.20M8.73M
Operating Income
-139.03M-129.53M-82.13M-60.45M-35.45M
Interest Income/Expense
8.44M1.36M-1.76M-6.51M1.83M
Other Income/Expense
N/AN/AN/AN/A330.00K
Non Recurring Items
-621.00KN/AN/AN/AN/A
Income Before Taxes
-131.21M-128.18M-83.89M-66.96M-33.30M
Income Tax
1.28MN/A0.00-630.00K800.00K
Net Income
-132.49M-128.18M-83.89M-66.34M-42.57M
EBITDA
-137.15M-127.85M-80.64M-58.83M-33.85M
 
Per Share Data
EPS Diluted Total Ops
-2.67-2.62-1.82-1.54-1.02
Non GAAP EPS
-2.66-2.63-1.82N/AN/A
 
Statistics
Profit Margin
-638.34%-412.15%-183.21%-199.82%-199.11%
Operating Profit Margin
-669.84%-416.50%-179.36%-182.08%-165.81%

All data in USD

Charts